{"id":"W4394872755","doi":"10.1002/cncr.35319","title":"Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma","year":2024,"lang":"en","type":"article","venue":"Cancer","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Institute of Cancer Research; University of Calgary","funders":"Seagen; GlaxoSmithKline","keywords":"Medicine; Pembrolizumab; Multiple myeloma; Internal medicine; Adverse effect; Refractory (planetary science); Oncology; Progressive disease; Immunotherapy; Gastroenterology; Cancer; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002431756,0.0003209726,0.0009283269,0.0003046827,0.0003641022,0.0006004765,0.0003506571,0.0004344066,0.0007935313],"category_scores_gemma":[0.002280517,0.0002247571,0.000689039,0.0002858996,0.0003413258,0.0005673862,0.0003164562,0.001149531,0.0002583722],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001010192,"about_ca_system_score_gemma":0.0008546953,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004454388,"about_ca_topic_score_gemma":0.0009232827,"domain_scores_codex":[0.9990326,0.0004453713,0.00008888281,0.0001498767,0.0001930422,0.00009026538],"domain_scores_gemma":[0.998664,0.000337499,0.0005070671,0.00009094706,0.00008823042,0.0003122252],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2353037,0.008013784,0.3225294,0.0007449692,0.002230107,0.0009187686,0.0006345074,0.003146412,0.04588094,0.0002070108,0.002124007,0.3782664],"study_design_scores_gemma":[0.05315552,0.3249618,0.5861568,0.0001976231,0.001822523,0.003785534,0.0002592974,0.006183915,0.01315956,0.0003627943,0.009894316,0.00006021763],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995558,0.002937142,0.0002227129,0.0001642352,0.00001799444,0.0001248084,0.0001659526,0.00002757192,0.0007815989],"genre_scores_gemma":[0.9988213,0.0003266312,0.0002526067,0.0001495914,0.00003436799,0.0000665795,0.0002053474,0.000002914117,0.0001406087],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002431756,"threshold_uncertainty_score":0.01286048,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01451326545748504,"score_gpt":0.2882694146390943,"score_spread":0.2737561491816092,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}